Flow Cytometry Services Market

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Flow Cytometry
3.3. Flow Cytometry Versus Conventional Analytical Techniques
3.4. Difference between Flow Cytometer, Cell Analyzer and Cell Sorter
3.5. Flow Cytometry Instrumentation
3.5.1. Flow Cytometry: Cell Analyzing and Counting Methodology
3.5.2. Flow Cytometry: Software and Automation Support
3.6. Flow Cytometry Services
3.7. Application of Flow Cytometry
3.8 Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Flow Cytometry Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters 
4.2.4. Analysis by Location of Flow Cytometry Facilities
4.2.5 Analysis by Type of Service(s) Offered
4.3.1. Analysis by Type of General Flow Cytometric Services Offered
4.3.2. Analysis by Type(s) of Analysis-based Flow Cytometric Services Offered
4.4. Analysis by Flow Cytometry Instrument Providers

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Key Parameters
5.4. Competitiveness Analysis: Flow Cytometry Service Providers
5.4.1. Companies offering Flow Cytometry Service Providers in North America
5.4.2 Companies offering Flow Cytometry Service Providers in Europe and Asia-Pacific

6. COMPANY PROFILES: FLOW CYTOMETRY SERVICE PROVIDERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. FlowMetric Life Sciences
6.2.1. Company Overview
6.2.2. FlowMetric Life Sciences: Flow Cytometry Services Portfolio
6.2.3. FlowMetric Life Sciences: Recent Developments and Future Outlook

6.3. Flow Contract Sites Laboratory
6.3.1. Company Overview
6.3.2. Flow Contract Sites Laboratory: Flow Cytometry Services Portfolio
6.3.3. Flow Contract Sites Laboratory: Recent Developments and Future Outlook

6.4. Bio-Legend
6.4.1. Company Overview
6.4.2. Bio-Legend: Flow Cytometry Services Portfolio
6.4.3. Bio-Legend: Recent Developments and Future Outlook

6.5. Q2 Solutions
6.5.1. Company Overview
6.5.2. Q2 Solutions: Flow Cytometry Services Portfolio
6.5.3. Q2 Solutions: Recent Developments and Future Outlook

7. COMPANY PROFILES: FLOW CYTOMETRY SERVICE PROVIDERS IN EUROPE AND ASIA-PACIFIC
7.1. Chapter Overview
7.2. ProImmune
7.2.1. Company Overview
7.2.2. ProImmune: Flow Cytometry Services Portfolio
7.2.3. ProImmune: Recent Developments and Future Outlook

7.3. MLM Medical Labs
7.3.1. Company Overview
7.3.2. MLM Medical Labs: Flow Cytometry Services Portfolio
7.3.3. MLM Medical Labs: Recent Developments and Future Outlook

7.4. Unilabs
7.4.1. Company Overview
7.4.2. Unilabs: Flow Cytometry Services Portfolio
7.4.3. Unilabs Recent Developments and Future Outlook

7.5. Firalis
7.5.1. Company Overview
7.5.2. Firalis: Flow Cytometry Services Portfolio
7.5.3. Firalis: Recent Developments and Future Outlook

7.6. Agilex Biolabs
7.6.1. Company Overview
7.6.2. Agilex Biolabs: Flow Cytometry Services Portfolio
7.6.3. Agilex Biolabs: Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Flow Cytometry Service Providers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Type of Collaborator
8.4. Flow Cytometry Service Providers: Information on Type of Service(s) Offered
8.4.1. Analysis by Type of Service(s)
8.4.2. Analysis by Type of Partnership and Type of Service(s)
8.4.3. Most of Active Players: Analysis by Number of Partnerships
8.5. Top Partners
8.6 Geographical Analysis
8.7. Intercontinental and Intracontinental Agreements

9. EFFICIENCY COMPARISON MODULE
9.1 Chapter Overview
9.2 Key Parameters 
9.3 Methodology
9.4 Flow Cytometry Efficiency Comparison Analysis
9.5 Inclusive Efficiency Comparison Analysis
9.6 Respective Efficiency Comparison Analysis
9.6.1 Flow Cytometry and Immunohistochemistry
9.6.2 Flow Cytometry and Cytogenetics Testing
9.6.3 Flow Cytometry and Fluorescence Microscopy
9.6.4 Flow Cytometry and ELISA
9.6.5 Flow Cytometry and Western Blotting
9.6.6 Flow Cytometry and Hematology Cell Analyzer
9.6.7 Flow Cytometry and Dynabead Method
9.7 Concluding Remarks

10. MARKET FORECAST
10.1 Chapter Overview
10.2 Forecast Methodology and Key Assumptions
10.3 Flow Cytometry Services Market, 2022-2035
10.4 Flow Cytometry Services Market, 2022 -2035: Analysis by Key Geographical Region
10.4.2 Flow Cytometry Services Market in North America, 2022-2035
10.4.2 Flow Cytometry Services Market in Europe, 2022-2035
10.4.3 Flow Cytometry Services Market in Asia-Pacific, 2022-2035
10.5 Conclusion

12. CONCLUDING REMARKS

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Manufacturer’s Landscape
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Market Forecast
Figure 3.1 Working Mechanism of Flow Cytometry
Figure 3.2 Flow Cytometry Services
Figure 4.1 Flow Cytometry Service Providers: Distribution by Year of Establishment
Figure 4.2 Flow Cytometry Service Providers: Distribution by Company Size
Figure 4.3 Flow Cytometry Service Providers: Distribution by Location of Headquarters
Figure 4.4 Flow Cytometry Service Providers: Distribution by Location of Flow Cytometry Facilities
Figure 4.5 Flow Cytometry Service Providers: Distribution by Type of Service(s) Offered
Figure 4.6 Flow Cytometry Services Providers: Distribution by Type of General Flow Cytometry Service Offered
Figure 4.7 Flow Cytometry Service Providers: Distribution by Type of Analysis-based Flow Cytometry Service(s) Offered
Figure 4.8 Flow Cytometry Instruments: Distribution by Instrument Provider
Figure 5.1 Company Competitiveness Analysis: Flow Cytometry Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: Flow Cytometry Service Providers in Europe and Asia-Pacific
Figure 8.1 Partnership and Collaborations: Cumulative Year-wise Trend, 2010-2021 (till July)
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership, 2010-2021 (till July)
Figure 8.3 Partnership and Collaboration: Distribution by Year and Type of Partnership, 2010-2021 (till July)
Figure 8.4 Partnerships and Collaborations: Distribution by the Type of Collaborator, 2010-2021 (till July 2021)
Figure 8.5 Partnership and Collaboration: Distribution by Type of Service(s)
Figure 8.6 Partnership and Collaboration: Distribution by Type of Partnership and Type of Service(s)
Figure 8.7 Most Active Players: Distribution by Number of Partnerships
Figure 8.8 Top Partners: Distribution by Number of partnerships
Figure 8.9 Partnership and Collaboration: Geographical Analysis
Figure 8.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.1 Inclusive Efficiency Comparison Analysis: Flow Cytometry with other Diagnostics Techniques
Figure 9.2 Efficiency Comparison Analysis: Flow Cytometry and Immunohistochemistry
Figure 9.3 Efficiency Comparison Analysis: Flow Cytometry and Cytogenetics Testing
Figure 9.4 Efficiency Comparison Analysis: Flow Cytometry and Fluorescence Microscopy
Figure 9.5 Individual Efficiency Comparison Analysis: Flow Cytometry and ELISA
Figure 9.6 Efficiency Comparison Analysis: Flow Cytometry and Western Blotting
Figure 9.7 Efficiency Comparison Analysis: Flow Cytometry and Hematology Cell Analyzer
Figure 9.8 Efficiency Comparison Analysis: Flow Cytometry and Dynabead Method
Figure 10.1 Flow Cytometry Services Market, 2022-2035 (USD Billion)
Figure 10.2 Flow Cytometry Services Market: Distribution by Key Geographical Regions, 2022 and 2035 (USD Million)
Figure 10.3 Flow Cytometry Services Market in North America, 2022-2035 (USD Billion)
Figure 10.4 Flow Cytometry Services Market in Europe, 2022-2035 (USD Billion)
Figure 10.5 Flow Cytometry Services Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 10.6 Flow Cytometry Services Market: Conservative, Base and Optimistic Scenarios,2022, 2028 and 2035 (USD Billion)
Figure 11.1 Concluding Remarks: Current Market Landscape of Flow Cytometry Service Providers
Figure 11.2 Concluding Remarks: Flow Cytometer Manufacturers
Figure 11.3 Concluding Remarks: Partnerships and Collaborations
Figure 11.4 Concluding Remarks: Market Forecast Analysis

List of Tables

Table 3.1 Difference between Flow Cytometer, Cell Analyzer and Cell Sorter
Table 4.1 Flow Cytometry Services Providers: List of Companies
Table 4.2 Flow Cytometry Service Providers: Information on Types of Services Offered
Table 4.3 List of Flow Cytometers: Information on Instrument Manufacturers,
Table 6.1 Flow Cytometry Services Providers in North America: List of Companies Profiled
Table 6.2 FlowMetric Life Sciences: Company Snapshot
Table 6.3 FlowMetric Life Sciences: Flow Cytometry Services Portfolio
Table 6.4 FlowMetric Life Sciences: Recent Developments and Future Outlook
Table 6.5 Flow Contract Site Laboratory: Company Snapshot
Table 6.6: Flow Contract Site Laboratory: Flow Cytometry Services Portfolio
Table 6.7 Flow Contract Site Laboratories: Recent Developments and Future Outlook
Table 6.8 Bio-Legend: Company Snapshot
Table 6.9 Bio-Legend: Flow Cytometry Services Portfolio
Table 6.10 Bio-Legend: Recent Developments and Future Outlook
Table 6.11 Q2 Solutions: Company Snapshot
Table 6.12 Q2 Solutions: Flow Cytometry Services Portfolio
Table 7.1 Flow Cytometry Service Providers in Europe: List of Companies Profiled
Table 7.2 ProImmune: Company Snapshot
Table 7.3 ProImmune: Flow Cytometry Services Portfolio
Table 7.4 ProImmune: Recent Developments and Future Outlook
Table 7.5 MLM Medical Labs: Company Snapshot
Table 7.6 MLM Medical Labs: Flow Cytometry Services Portfolio
Table 7.7 MLM Medical Labs: Recent Developments and Future Outlook
Table 7.8 Unilabs (Serving Pharma Facility): Company Snapshot
Table 7.9 Unilabs: Flow Cytometry Services Portfolio
Table 7.10 Unilabs: Recent Developments and Future Outlook
Table 7.11 Firalis: Company Snapshot
Table 7.12 Firalis: Flow Cytometry Services Portfolio
Table 7.13 Firalis: Recent Developments and Future Outlook
Table 7.14 Agilex Biolabs: Company Snapshot
Table 7.15 Agilex Biolabs: Flow Cytometry Services Portfolio
Table 7.16 Agilex Biolabs: Recent Developments and Future Outlook
Table 8.1 Flow Cytometry Services Market: List of Partnerships
Table 8.2 Partnerships and Collaborations: Information on the Type of Service(s)`
Table 12.1 Flow Cytometry Service Providers: Distribution by Year of Establishment
Table 12.2 Flow Cytometry Service Providers: Geographical Distribution by Company Size
Table 12.3 Flow Cytometry Service Providers: Distribution by Location of Headquarters
Table 12.4 Flow Cytometry Service Providers: Distribution by Location of Flow Cytometry Facilities
Table 12.5 Flow Cytometry Service Providers: Distribution by Type of Service(s) Offered
Table 12.6 Flow Cytometry Manufacturers: Distribution by Number of Instrument offered
Table 12.7 Partnerships and Collaborations: Cumulative Year-wise Trend, 2010-2021
Table 12.8 Partnerships and Collaborations: Distribution by Type of Partnership
Table 12.9 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 12.10 Partnerships and Collaborations: Distribution by Type of Partner
Table 12.11 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Table 12.12 Partnerships and Collaborations: Distribution by Type of Services and Type of Partnership
Table 12.13 Most Active Players: Distribution by Number of Partnerships
Table 12.14 Top Partners: Distribution by Number of Partnerships
Table 12.15 Partnerships and Collaborations: Distribution by Geography
Table 12.16 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
Table 12.17 Flow Cytometry Services Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.18 Flow Cytometry Services Market: Distribution by Key Geographical Regions, 2022 and 2035 (USD Billion)
Table 12.19 Flow Cytometry Services Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.20 Flow Cytometry Services Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.21 Flow Cytometry Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)

List of Companies

Please reach out to our team for more details.